åsa Mellbring
About åsa Mellbring
Åsa Mellbring serves as the Director of Cell Therapy and Oncology Medical Affairs for the Nordics at Kite Pharma, Inc. She has extensive experience in the oncology field, having held various medical roles at notable companies including Baxter International Inc., Roche, and Shire.
Current Role at Kite Pharma
Åsa Mellbring serves as the Director of Cell Therapy and Oncology Medical Affairs for the Nordics at Kite Pharma, Inc. She has held this position since 2018, contributing to the company's strategic direction in cell therapy and oncology within the Nordic region. Her role involves overseeing medical affairs initiatives, ensuring alignment with corporate objectives, and fostering collaborations with healthcare professionals.
Previous Experience at Kite Pharma
Prior to her current role, Åsa Mellbring worked as the Associate Director and Medical Lead for Cell Therapy at Kite Pharma, Inc. for a brief period of two months in 2018. This position allowed her to engage in critical projects related to cell therapy, further enhancing her expertise in the field.
Experience at Baxter International Inc.
Åsa Mellbring was employed at Baxter International Inc. as a Medical Advisor for Oncology and Hematology in the Nordics from 2014 to 2015. During her tenure, she focused on providing medical guidance and support for oncology and hematology products, contributing to the company's medical affairs in the region.
Educational Background
Åsa Mellbring studied at Karolinska Institutet, where she earned a Doctorate in Philosophy in 2003. Additionally, she has been associated with KTH Global Development Hub since 1997, furthering her academic and professional development in relevant fields.
Career at Roche
Åsa Mellbring spent seven years at Roche, where she held the position of Country Medical Manager for Oncology from 2007 to 2014. She also worked as a Product Specialist for Breast Cancer from 2005 to 2007. Her roles at Roche involved managing medical strategies and product development in oncology, contributing to the company's success in the therapeutic area.